Paxlovid, Pfizer’s oral COVID-19 pill, set to be approved in Canada

Email not displaying correctly? View this email in your browser Follow us:   BREAKING NEWS January 17, 2022     HEALTH January 17, 2022 9:39 am January 17, 2022 9:39 am Paxlovid, Pfizer's oral COVID-19 pill, set to be approved in Canada Pfizer began a rolling submission with Health Canada in December for Paxlovid, which it said is designed to block a key enzyme needed for the COVID-19 virus to multiply. Continue reading →   This email was sent to globalnews@quicklydone.com Why did I get this?  |  Manage my subscription  |  Unsubscribe here © Global News, a division of Corus Entertainment Inc., 2022. All rights reserved. Global News, a division of Corus Entertainment Inc. Corus Quay. 25 Dockside Drive, Toronto, ONTARIO M5A 0B5. Canada.